Topic - Provenge

Sipuleucel-T (APC8015, Provenge), manufactured by Dendreon Corporation, is a therapeutic cancer vaccine for prostate cancer (CaP). It must be prepared specifically for each patient. In metastatic prostate cancer, it has extended survival by about six months. It costs about $100,000 for a course of treatment. - Source: Wikipedia